Richard Dean Dr McCormick
Richard Dean Dr McCormick (R-GA) sold $1K-$15K of $BLK (BlackRock, Inc. Common Stock) on Sep 18, 2025, part of 4 transactions in this filing.
HillSignal flagged 5 timing concerns on this filing — trades that line up closely with related legislative or contract activity.
Price Movement Since Trade
How the largest positions have moved from the trade date to the most recent close.
Suspicious Timing Detected
5 flagsRichard Dean Dr McCormick sold $1,001 - $15,000 in $BLK on 2025-09-18 — 1 day AFTER the Billionaires Income Tax Act (HR5427) was introduced, a bill that could impact high-net-worth individuals and investment firms.
Richard Dean Dr McCormick sold $1,001 - $15,000 in $UNH on 2025-09-18 — 82 days BEFORE the 'Putting Patients First Healthcare Freedom Act' (HR6512) was introduced, a bill that aims to reduce revenue for large health insurers.
Richard Dean Dr McCormick sold $1,001 - $15,000 in $UNH on 2025-09-18 — 84 days BEFORE the 'Pharmacists Fight Back in Medicare and Medicaid Act' (HR6609) was introduced, a bill targeting Pharmacy Benefit Managers (PBMs).
These flags identify timing coincidences between stock trades and legislative activity. They do not imply wrongdoing. Click any bill number or ticker to see the full analysis.
Share This Filing
All Transactions
| Type | Ticker | Asset | Amount | Trade Price | Current | Change | Date |
|---|---|---|---|---|---|---|---|
| PARTIAL SELL | $BLK | BlackRock, Inc. Common Stock | $1K-$15K | $1,137.13 | — | — | Sep 18, 2025 |
| PARTIAL SELL | $LHX | L3Harris Technologies, Inc. Common Stock | $1K-$15K | $282.73 | — | — | Sep 18, 2025 |
| PARTIAL SELL | $MSFT | Microsoft Corporation - Common Stock | $1K-$15K | $508.45 | — | — | Sep 18, 2025 |
| PARTIAL SELL | $UNH | UnitedHealth Group Incorporated Common Stock | $1K-$15K | $334.82 | — | — | Sep 18, 2025 |
Connected Legislative Activity
10 signalsThese bills and contracts share tickers or sectors with this filing's trades.
Puerto Rico Affordable Care Act of 2025
HR6479 is an early-stage bill with no near-term path to enactment. Recent managed care stock rallies are tied to general sector optimism, not this specific legislation. No actionable trading signal from this bill at this point.
ACO Assignment Improvement Act of 2025
The ACO Assignment Improvement Act of 2025 widens Medicare Shared Savings Program attribution to include NP and PA visits. This directly benefits ACO operators among major Medicare Advantage insurers (UNH, HUM, CVS, CNC, MOH) by expanding their addressable patient pool for shared savings without additional provider recruitment. The bill is at early legislative stage with a bipartisan Senate sponsorship, but the mechanism is structurally favorable for the sector.
Association Health Plans Act
The Association Health Plans Act (HR2528) has advanced to the Union Calendar, expanding the addressable market for health insurers in the small group sector by allowing cross-industry associations to offer coverage. The six major health insurer stocks have shown strong positive performance over the past 7 and 30 days, with the legislative catalyst reinforcing bullish momentum in the sector.
ERISA Litigation Reform Act
HR6084, the ERISA Litigation Reform Act, has cleared the House Education & Workforce Committee on a party-line 19-13 vote and awaits floor action. The bill imposes a mandatory discovery stay during motions to dismiss and heightens pleading standards for ERISA fiduciary lawsuits, directly reducing legal costs and liability exposure for major financial institutions serving as retirement plan fiduciaries. BlackRock ($BLK), Charles Schwab ($SCHW), Morgan Stanley ($MS), JPMorgan Chase ($JPM), and Bank of America ($BAC) are the primary beneficiaries.
Putting Patients First Healthcare Freedom Act
HR6512, the Putting Patients First Healthcare Freedom Act, is an early-stage bill that would eliminate enhanced ACA premium subsidies, directly threatening $5-9 billion in annual premium revenue for UnitedHealth, Humana, Centene, and Molina. The bill has only 3 sponsors and 4 committee referrals, making passage unlikely in its current form, but the structural risk to the managed care sector is clearly defined. Despite the legislative risk, actual market data shows all four tickers surging over the past 30 days ($CNC +64%, $MOH +47%, $HUM +40%, $UNH +36%), indicating the market is pricing in a 'do nothing' outcome for this specific legislation.
Pharmacists Fight Back in Medicare and Medicaid Act
HR6609 is an early-stage bill that would mandate rebate pass-throughs and ban patient steering by PBMs in Medicare and Medicaid. The bill has 36 cosponsors but remains in committee since December 2025 with no further action — legislative probability is low near-term. Despite real headwinds for CVS, CI, UNH, and ELV, the market has rallied these names 3-10% in the past week and 8-42% in 30 days on unrelated earnings and sector rotation, not this bill.
SAFE BOTs Act
The SAFE BOTs Act (HR6489) is a procedural, early-stage bill requiring AI chatbot providers to disclose their non-human nature to minors and implement basic content moderation policies. It contains zero funding, zero spending authorizations, and zero direct financial penalties. For major public chatbot operators (GOOGL, META, MSFT, AMZN), this represents a negligible compliance cost. The bill is in early committee stage with a long path to law — no market-moving impact.
Retirement Simplification and Clarity Act
HR6324 is an early-stage, zero-funding tax code bill that would permit in-service 401(k) rollovers into individual retirement annuities for participants age 50+. The bill was referred to the House Ways and Means Committee on November 28, 2025, and has seen zero legislative activity since. This is a structural expansion of the annuity-eligible asset base, benefiting asset managers and custodians ($BLK, $SCHW, $MS, $JPM), but the legislative path is long with no floor votes scheduled. Real market data shows a mixed 30-day performance across financials — $MS +14.84% and $BLK +10.55% significantly outperforming $SCHW -1.95% — but these moves are driven by broader macro and earnings, not this bill.
HUSTLE Act
The HUSTLE Act (S.3378) is an early-stage bill introduced in December 2025 proposing tax-exempt NIL investment accounts for student-athletes. It has been referred to the Senate Committee on Finance and has not advanced. The bill has no funding authorization and minimal near-term market impact. Financial services stocks like $SCHW and $PYPL show mixed performance over the past 7 days, with no correlation to this legislation.
Ensuring Excellence in Mental Health Act
The Ensuring Excellence in Mental Health Act expands Medicare and Medicaid coverage for Certified Community Behavioral Health Clinics (CCBHCs), creating a new revenue stream for managed care organizations via established prospective payment systems. The bill is in early committee stage with three cosponsors and bipartisan support, but actual appropriations are separate. Real market data shows UNH, CNC, and MOH have seen massive recent rallies — CNC up 28% in 7 days and 63.5% in 30 days, MOH up 10.89% in 7 days, UNH up 36.12% in 30 days — indicating the market is already pricing in tailwinds from this and related behavioral health policy moves.
Other Filings by Richard Dean Dr McCormick
Free — no credit card
Get the next McCormick trade the day it's disclosed
HillSignal tracks every Congressional stock filing and federal contract, scores its market impact with AI, and emails you the ones that matter — before they hit the news.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →
Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.